Powered by RND
PodcastsCienciasPharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive Podcast
Pharmaceutical Executive
Último episodio

Episodios disponibles

5 de 207
  • Pharmaceutical Executive Daily: Why DSCSA Compliance is Only The Beginning
    In today’s Pharmaceutical Executive Daily, we cover the FDA’s approval of Johnson & Johnson’s Simponi for pediatric ulcerative colitis, why DSCSA compliance is only the beginning of pharma supply chain modernization, and the agency’s approval of Jascayd for idiopathic pulmonary fibrosis.
    --------  
    2:37
  • Pharmaceutical Executive Daily: Amgen Launches New Direct-To-Consumer Platform
    In today’s Pharmaceutical Executive Daily, we explore why medical AI success depends on more than algorithms, Amgen’s launch of its new direct-to-consumer platform AmgenNow, and AstraZeneca’s multi-target research partnership with Algen.
    --------  
    3:00
  • Pharmaceutical Executive Daily: FDA Lifts Clinical Hold on NUZ-001
    In today’s Pharmaceutical Executive Daily, we cover the FDA lifting its clinical hold on Neurizon Therapeutics’ lead program Nuz-001, the agency’s export ban on Sun Pharma’s Halol facility, and new insights on how small biotechs can better navigate regulatory and market complexities.
    --------  
    2:56
  • Pharmaceutical Executive Daily: Updated Vaccine Recommendations
    Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Pharmaceutical Executive Daily, we cover lessons from FDA complete response letters shaping CMC strategy in cell and gene therapy, Takeda’s decision to discontinue its cell therapy research programs, and the CDC’s latest update to COVID-19 vaccination recommendations.
    --------  
    2:40
  • Pharmaceutical Executive Daily: FDA's new Fast-Track Review
    In today’s Pharmaceutical Executive Daily, we cover the FDA’s new fast-track review program for U.S.-made generics, Novartis’ FDA approval of Rhapsido for chronic spontaneous urticaria, and Halozyme’s $750 million acquisition of Elektrofi to strengthen drug delivery innovation.
    --------  
    2:49

Más podcasts de Ciencias

Acerca de Pharmaceutical Executive

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. 
Sitio web del podcast

Escucha Pharmaceutical Executive, Horizonte – Iker Jiménez y muchos más podcasts de todo el mundo con la aplicación de radio.es

Descarga la app gratuita: radio.es

  • Añadir radios y podcasts a favoritos
  • Transmisión por Wi-Fi y Bluetooth
  • Carplay & Android Auto compatible
  • Muchas otras funciones de la app
Aplicaciones
Redes sociales
v7.23.9 | © 2007-2025 radio.de GmbH
Generated: 10/10/2025 - 6:57:06 PM